Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Man City beat Chelsea to revive Premier League race

    April 13, 2026

    EU carbon market emissions fall 1.3% in 2025

    April 11, 2026

    Moscow opens T2 on record urban tram route

    April 11, 2026
    Trending
    • Man City beat Chelsea to revive Premier League race
    • EU carbon market emissions fall 1.3% in 2025
    • Moscow opens T2 on record urban tram route
    • European wheat extends losses on ample global supply
    • European Commission says Hormuz passage must stay free
    • UK set for warmest day of 2026 before sharp cooldown
    • Russian study finds spruce compounds slow blood clotting
    • WHO urges global support for science on World Health Day
    • Home
    • Contact Us
    Evening Post LondonEvening Post London
    Tuesday, April 14
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Evening Post LondonEvening Post London
    Home » Australia reviews approval to grow genetically modified purple tomato
    Health

    Australia reviews approval to grow genetically modified purple tomato

    June 17, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Australian regulators are reviewing a proposal to approve the cultivation and sale of a genetically modified purple tomato, potentially expanding the nation’s limited list of approved genetically modified (GM) crops. If successful, the tomato could be commercially available by next year, with initial production planned in greenhouses in south-east Queensland. Developed by UK-based scientists and commercialized by U.S. firm Norfolk Healthy Produce, the purple tomato has been engineered to contain genes from the snapdragon flower.

    These genes enable the tomato to produce anthocyanins, naturally occurring antioxidants also found in blueberries, blackberries, and eggplant skins. The resulting pigmentation gives the tomato its distinct purple hue. Dr. Nathan Pumplin, Chief Executive of Norfolk Healthy Produce, said the tomato offers enhanced nutritional properties without altering its essential nature. “It’s just a tomato,” he said, “what’s special is that it contains the same antioxidants found in other purple fruits.”

    The research behind the product originated at the John Innes Centre in the UK, led by Professor Cathie Martin. A co-founder of Norfolk Plant Sciences, Professor Martin is a recognized authority on the nutritional content of fruit and vegetables. Her research culminated in the development of the purple tomato after 18 years of work, earning her the prestigious Rank Prize for Nutrition. The tomato has already gained regulatory approval in the United States, where it has been sold for two years.

    In 2024 alone, over 100,000 punnets of the fruit and 13,000 seed packets were sold across the country. Following this success, the company is targeting international markets, including Australia and Canada. In Australia, All Aussie Farmers, a Victorian produce marketing company, has partnered with Norfolk to distribute the fruit domestically. Managing Director Travis Murphy said the product has generated strong interest from both retailers and chefs. Pending regulatory approval, initial rollout will be in Melbourne.

    Australia maintains strict oversight on GM crops, with only five currently approved: canola, cotton, safflower, bananas, and flowers. The Office of the Gene Technology Regulator (OGTR) is assessing the safety of the purple tomato for human health and environmental impact. A public consultation period will commence in September as part of the review process. In addition, Food Standards Australia New Zealand will conduct a safety assessment before the product is cleared for consumption. Experts such as Professor James Dale from Queensland University of Technology note that the approval process is rigorous, often requiring extensive documentation and trial data to ensure safety and compliance. – By MENA Newswire News Desk.

    Related Posts

    Russian study finds spruce compounds slow blood clotting

    April 8, 2026

    WHO urges global support for science on World Health Day

    April 7, 2026

    EU commits 225 million euros for next-gen flu vaccines

    February 24, 2026

    WHO clears another nOPV2 polio vaccine for global UNICEF use

    February 14, 2026

    WHO and IARC say 37% of cancer cases are preventable

    February 4, 2026

    Russia researchers develop berberine cheese to support immunity

    January 28, 2026
    Latest News

    Man City beat Chelsea to revive Premier League race

    April 13, 2026

    EU carbon market emissions fall 1.3% in 2025

    April 11, 2026

    Moscow opens T2 on record urban tram route

    April 11, 2026

    European wheat extends losses on ample global supply

    April 11, 2026

    European Commission says Hormuz passage must stay free

    April 11, 2026

    UK set for warmest day of 2026 before sharp cooldown

    April 8, 2026

    Russian study finds spruce compounds slow blood clotting

    April 8, 2026

    WHO urges global support for science on World Health Day

    April 7, 2026
    © 2024 Evening Post London | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.